Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 256 participants.

Also called NCT06246799

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 3
Enrolled
  • 256 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06246799
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06246799. Randomized; no masking; primary purpose other. Start 2024-11-07 (actual); primary completion 2029-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Condition
Type 2 Diabetes (Adult Onset)
Intervention (Drug)
Tirzepatide
Intervention (Drug)
Pioglitazone
Intervention (Drug)
Sitagliptin
Intervention (Drug)
Metformin HCI XR
Lead sponsor
The University of Texas Health Science Center at San Antonio (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06246799
Content hash
ecfc2f101d8b3a07d1370a47cd2cc3cedee533c5f118c39a3c49768051942160